|
KMID : 1100220030020020108
|
|
Dementia and Neurocognitive Disorders
2003 Volume.2 No. 2 p.108 ~ p.114
|
|
|
Treatment of Mild Cognitive Impairment
|
|
Bae Hee-Joon
|
|
|
Abstract
|
|
|
|
Mild cognitive impairment (MCI) is a recently described syndrome that is currently thought of as a transition phase between healthy cognitive aging and dementia. At the moment, many treatment strategies for Alzheimer’s disease were extrapolated to interventional strategies in MCI. Most investigators believe that by the time the clinical diagnosis of Alzheimer’s disease is made, sufficient neuronal damage has taken place in the brain to make reversal of the condition unlikely. Therefore, it is a more effective strategy to treat patients in preclinical stage of Alzheimer’s disease, such as MCI, than to treat in its advanced stage. This article reviews currently available symptomatic treatments and visionary treatments for Alzheimer’s disease and MCI. A number of clinical trials for MCI, which are ongoing at now, are discussed.
|
|
|
KEYWORD
|
|
|
Mild cognitive impairment, Alzheimer’s disease, Treatment
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|